KLHL5 and gastric neoplasm: Oncomine data showed that the overexpression of KLHL5 was identified in many malignancies like brain, cervical, breast, esophageal, colorectal, and gastric tumors, whereas it was downregulated in cancer tissues of bladder, lung, prostate, and so on in some microarrays (Figure 1A).